Elevance Health
662 hedge funds and large institutions have $25B invested in Elevance Health in 2014 Q1 according to their latest regulatory filings, with 76 funds opening new positions, 198 increasing their positions, 286 reducing their positions, and 47 closing their positions.
62% more first-time investments, than exits
New positions opened: 76 | Existing positions closed: 47
30% more funds holding in top 10
Funds holding in top 10: 23 → 30 (+7)
28% more call options, than puts
Call options by funds: $231M | Put options by funds: $180M
6% more capital invested
Capital invested by funds: $23.6B → $25B (+$1.41B)
3% more funds holding
Funds holding: 640 → 662 (+22)
31% less repeat investments, than reductions
Existing positions increased: 198 | Existing positions reduced: 286
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCM
Glenview Capital Management
New York
|
+$383M |
| 2 |
BNP Paribas Financial Markets
Paris,
France
|
+$352M |
| 3 |
Allianz Asset Management
Munich,
Germany
|
+$323M |
| 4 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$145M |
| 5 |
VVP
Vulcan Value Partners
Birmingham,
Alabama
|
+$125M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barrow, Hanley, Mewhinney & Strauss
Dallas,
Texas
|
-$385M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$258M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$182M |
| 4 |
Capital World Investors
Los Angeles,
California
|
-$181M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$159M |
ELV Hedge Fund Activity: Q1 2014 in Review
662 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Elevance Health (ELV) for Q1 2014, worth a combined $25B — up 5.9% from $23.6B a quarter earlier.
Buyers outnumbered sellers: 76 funds opened new ELV positions and 47 closed out — a net gain of 29 holders — while 198 added to existing stakes and 286 trimmed.
The largest buyer was Glenview Capital Management, opening a new position worth an estimated $383M. The largest seller was Barrow, Hanley, Mewhinney & Strauss, cutting an estimated $385M.
- 662 institutional investors held Elevance Health (ELV) as of Q1 2014, up from 640 in Q4 2013.
- Funds reported $25B of Elevance Health stock for Q1 2014, up 5.9% quarter-over-quarter.
- 76 funds opened new Elevance Health positions in Q1 2014 and 47 closed out, a net change of +29 holders.
- The largest Elevance Health buyer in Q1 2014 was Glenview Capital Management, an estimated $383M added.
- The largest Elevance Health seller in Q1 2014 was Barrow, Hanley, Mewhinney & Strauss, an estimated $385M sold.
Based on aggregated 13F filings for Q1 2014.